Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
Clinical trial NCT00664287 · WITHDRAWN
Trial details
- NCT number
- NCT00664287
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.